Terms of Service and License AgreementTerms of Service and License Agreement • November 7th, 2020 • North Carolina
THIS AGREEMENT IS SUBJECT TO CHANGE FROM TIME TO TIME AS DETERMINED BY BANDWIDTH.COM IN ITS SOLE DISCRETION. MODIFIED AND/OR UPDATED VERSIONS OF THIS AGREEMENT WILL BE POSTED AT WWW.PHONEBOOTH.COM/LEGAL/TERMSOFSERVICE.
Ascvd guidelines calculatorTerms of Service and License Agreement • January 29th, 2022
This Terms of Service and License Agreement constitutes a legal agreement (collectively, the "Agreement") between the American College of Cardiology Foundation ("ACCF") and You and your agents ("You") for the use of ASCVD Risk Estimator Plus (the "Product"), whether You use the mobile application version of the Product or the web version of the Product. No waiver of any rights or consent to any breaches shall constitute a waiver of any other rights or consent to any other breach. You may not modify, publish, transmit, participate in the transfer or sale of, reproduce, create derivative works from, distribute, perform, display, incorporate into another website, or in any other way exploit the Service and/or any of the Content, in whole or in part. Both the mediation and arbitration will be conducted by JAMS applying the laws of the District of Columbia without regard to its conflicts of laws principles and in the District of Columbia as venue. The material is not intended to present the
TERMS OF SERVICE AND LICENSE AGREEMENTTerms of Service and License Agreement • June 15th, 2020 • Texas
This Beta Program License Agreement (the "Agreement") is an addendum to the Master Service Agreement as incorporated by reference. This Agreement is made between Fonality, Inc., (a/k/a “NetFortris”) a Delaware corporation, with its principal place of business located at 5340 Legacy Drive, Suite 155, Plano, TX 75024 USA ("NetFortris") and you ("Customer") for the purpose of testing a beta version of certain NetFortris software or service commonly known as Comm-unitY (the "Service").
Ascvd risk assessment guidelinesTerms of Service and License Agreement • May 7th, 2021
This Terms of Service and License Agreement constitutes a legal agreement (collectively, the "Agreement") between the American College of Cardiology Foundation ("ACCF") and You and your agents ("You") for the use of ASCVD Risk Estimator Plus (the "Product"), whether You use the mobile application version of the Product or the web version of the Product. The Product allows You to access certain content included in the Product ("Content") relating to calculation of ASCVD Risk and corresponding guideline advice. By using the Product, You accept and agree to be bound by all of the terms and conditions set forth in this Agreement. If You do not wish to accept the terms and conditions of this Agreement, You may not proceed to use the Product. ACCF may change the terms of this Agreement from time to time without further notice directly to You. When the terms are changed, ACCF will post a general conspicuous notice. If You do not agree with the revised terms, please discontinue use of the Prod
How to calculate bilirubinTerms of Service and License Agreement • August 7th, 2021
This Terms of Service and License Agreement constitutes a legal agreement (collectively, the "Agreement") between the American College of Cardiology Foundation ("ACCF") and You and your agents ("You") for the use of ASCVD Risk Estimator Plus (the "Product"), whether You use the mobile application version of the Product or the web version of the Product. The Product allows You to access certain content included in the Product ("Content") relating to calculation of ASCVD Risk and corresponding guideline advice. By using the Product, You accept and agree to be bound by all of the terms and conditions set forth in this Agreement. If You do not wish to accept the terms and conditions of this Agreement, You may not proceed to use the Product. ACCF may change the terms of this Agreement from time to time without further notice directly to You. When the terms are changed, ACCF will post a general conspicuous notice. If You do not agree with the revised terms, please discontinue use of the Prod
